UCB at EBF 2026

Nov 17–19, 2026 Barcelona, Spain ~800 attendees Website

UCB brings 2 presentations to EBF 2026 in Barcelona. Its program covers routine use of surrogate matrices in regulated bioanalysis and droplet digital PCR for biodistribution studies when tissue matrix interferes.

Organization	EBF 2026 Attendance
UCB Brussels, Belgium
ucb.com Pharma Biopharmaceutical company developing medicines for immunology and neurology, including epilepsy and inflammatory diseases.	Talk Tue Nov 17 3–3:20pm Part of Session 4: Advancing the 3Rs: Smarter Sampling, Surrogate Matrices and Leaner Workflows Routine use of surrogate matrix in regulated bioanalysis Sampling Talk Tue Nov 17 5–5:20pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR Overcoming tissue matrix interference in a droplet digital PCR analytical method for biodistribution assessment PCR

Organization

EBF 2026 Attendance

UCB

Brussels, Belgium

ucb.com

Pharma

Biopharmaceutical company developing medicines for immunology and neurology, including epilepsy and inflammatory diseases.

Talk

Tue Nov 17
3–3:20pm

Part of Session 4: Advancing the 3Rs: Smarter Sampling, Surrogate Matrices and Leaner Workflows

Routine use of surrogate matrix in regulated bioanalysis

Sampling